InvestorsHub Logo
Followers 0
Posts 178
Boards Moderated 0
Alias Born 11/19/2017

Re: None

Wednesday, 01/10/2018 2:21:37 PM

Wednesday, January 10, 2018 2:21:37 PM

Post# of 43787
They don't even need arb $ if phase 3 reports this year. Ergomed already partnered via share pickup so to speak. And they have data which seems conclusive speculatively given their confidence to take a big block of shares for years of work. Its not difficult to find further partners for the home stretch if need be. People acting like theyre desperate. Cash strapped. Yeah a year ago when everything was in limbo. Now its a moot argument. Market cap way low here for potential outcome. The product has an enormous market potential. Its not just any promising phase 3 drug.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News